Stock exchanges & markets

Overview Watchlists

AstraZeneca partners with Oracle to optimize clinical trials using AI

20. Oct 2026

(AWP Alliance News) - AstraZeneca and Oracle Health and Life Sciences entered a global AI collaboration to improve clinical trial recruitment and patient care. The partnership will combine scientific expertise with real-world data and AI-enabled clinical tools across projects in the US, Middle East and Europe.

The first program, with healthcare company M42 in Abu Dhabi, will focus on hypertension care and clinical trial recruitment. The companies signed a nonbinding term sheet.

https://www.publicnow.com/view/9947BBBB06EE770935C14C2C3F73424103DAA472…

Disclaimer: This news brief was created using generative artificial intelligence. AstraZeneca plc published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now